Virchows Archiv : an international journal of pathology
Validation of IHC4 + C for male breast cancer.
Carmen van der Pol, Anne de Hond, Dieuwke Mink van der Molen, Quirine Manson, Inne Borel-Rinkes, Arjen Witkamp, Elsken van der Wall, Helena Verkooijen, Paul van Diest
Published: 202610.1007/s00428-025-04386-x
Abstract
Male breast cancer (MBC) is a rare disease accounting for less than 1% of all breast cancers. MBC is almost always of the estrogen receptor (ER) positive luminal subtype. Although differences have been described between male and female breast cancers…
Preview only. Read the full abstract at the source